Cell surface display system for Lactococcus lactis: A novel development for oral vaccine

The food-grade Lactococcus lactis is a potential vector to be used as a live vehicle for the delivery of heterologous proteins for vaccine and pharmaceutical purposes. We constructed a plasmid vector pSVac that harbors a 255-bp single-repeat sequence of the cell wall-binding protein region of the Ac...

Full description

Bibliographic Details
Main Authors: Foo, H.L (Author), Raha, A.R (Author), Ross, E. (Author), Varma, N.R.S (Author), Yusoff, K. (Author)
Format: Article
Language:English
Subjects:
Online Access:View Fulltext in Publisher
View in Scopus
LEADER 05179nam a2200997Ia 4500
001 10.1007-s00253-004-1851-8
008 220112s2005 CNT 000 0 und d
020 |a 01757598 (ISSN) 
245 1 0 |a Cell surface display system for Lactococcus lactis: A novel development for oral vaccine 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1007/s00253-004-1851-8 
856 |z View in Scopus  |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-23944501101&doi=10.1007%2fs00253-004-1851-8&partnerID=40&md5=14bf84482c9a9d83cec2a521946fa166 
520 3 |a The food-grade Lactococcus lactis is a potential vector to be used as a live vehicle for the delivery of heterologous proteins for vaccine and pharmaceutical purposes. We constructed a plasmid vector pSVac that harbors a 255-bp single-repeat sequence of the cell wall-binding protein region of the AcmA protein. The recombinant plasmid was transformed into Escherichia coli and expression of the gene fragment was driven by the T7 promoter of the plasmid. SDS-PAGE showed the presence of the putative AcmA′ fragment and this was confirmed by Western blot analysis. The protein was isolated and purified using a His-tag affinity column. When mixed with a culture of L. lactis MG1363, ELISA and immunofluorescence assays showed that the cell wall-binding fragment was anchored onto the outer surface of the bacteria. This indicated that the AcmA′ repeat unit retained the active site for binding onto the cell wall surface of the L. lactis cells. Stability assays showed that the fusion proteins (AcmA/A1, AcmA/A3) were stably docked onto the surface for at least 5 days. The AcmA′ fragment was also shown to be able to strongly bind onto the cell surface of naturally occurring lactococcal strains and Lactobacillus and, with less strength, the cell surface of Bacillus sphericus. The new system designed for cell surface display of recombinant proteins on L. lactis was evaluated for the expression and display of A1 and A3 regions of the VP1 protein of enterovirus 71 (EV71). The A1 and A3 regions of the VP1 protein of EV71 were cloned upstream to the cell wall-binding domains of AcmA protein and successfully expressed as AcmA/A1 and AcmA/A3. Whole-cell ELISA showed the successful display of VP1 protein epitopes of EV71 on the surface of L. lactis. The success of the anchoring system developed in this study for docking the A1 and A3 epitopes of VP1 onto the surface of L. lactis cells opens up the possibilities of peptide and protein display for not only Lactococcus but also for other gram-positive bacteria. This novel way of displaying epitopes on the cell surface of L. lactis and other related organisms should be very useful in the delivery of vaccines and other useful proteins. © Springer-Verlag 2005. 
650 0 4 |a amino acid sequence 
650 0 4 |a article 
650 0 4 |a Assays 
650 0 4 |a autolysin 
650 0 4 |a Bacillus sphaericus 
650 0 4 |a Bacteria 
650 0 4 |a bacterial cell 
650 0 4 |a bacterial enzyme 
650 0 4 |a bacterial genetics 
650 0 4 |a bacterial strain 
650 0 4 |a bacterium culture 
650 0 4 |a binding affinity 
650 0 4 |a binding site 
650 0 4 |a Blot analysis 
650 0 4 |a cell surface 
650 0 4 |a cell wall 
650 0 4 |a Cell Wall 
650 0 4 |a Cells 
650 0 4 |a drug carrier 
650 0 4 |a Enterovirus 71 
650 0 4 |a enzyme linked immunosorbent assay 
650 0 4 |a epitope 
650 0 4 |a Epitopes 
650 0 4 |a Escherichia coli 
650 0 4 |a gene construct 
650 0 4 |a gene expression 
650 0 4 |a Gene Expression 
650 0 4 |a Gene fragments 
650 0 4 |a Genes 
650 0 4 |a Gram positive bacterium 
650 0 4 |a Human enterovirus 71 
650 0 4 |a hybrid protein 
650 0 4 |a immunofluorescence 
650 0 4 |a Immunofluorescence 
650 0 4 |a Lactobacillus 
650 0 4 |a Lactobacillus delbrueckii 
650 0 4 |a Lactobacillus vaccine 
650 0 4 |a Lactococcus 
650 0 4 |a Lactococcus lactis 
650 0 4 |a Membrane Proteins 
650 0 4 |a microbiology 
650 0 4 |a molecular cloning 
650 0 4 |a Muramidase 
650 0 4 |a n acetylmuraminidase 
650 0 4 |a nonhuman 
650 0 4 |a Organisms, Genetically Modified 
650 0 4 |a plasmid vector 
650 0 4 |a Plasmids 
650 0 4 |a polyacrylamide gel electrophoresis 
650 0 4 |a Posibacteria 
650 0 4 |a promoter region 
650 0 4 |a protein binding 
650 0 4 |a Protein Binding 
650 0 4 |a protein domain 
650 0 4 |a protein expression 
650 0 4 |a protein isolation 
650 0 4 |a protein purification 
650 0 4 |a protein stability 
650 0 4 |a protein VP1 
650 0 4 |a Proteins 
650 0 4 |a Recombinant Fusion Proteins 
650 0 4 |a recombinant plasmid 
650 0 4 |a recombinant protein 
650 0 4 |a surface property 
650 0 4 |a unclassified drug 
650 0 4 |a Vaccines 
650 0 4 |a Vaccines, Synthetic 
650 0 4 |a Western blotting 
700 1 0 |a Foo, H.L.  |e author 
700 1 0 |a Raha, A.R.  |e author 
700 1 0 |a Ross, E.  |e author 
700 1 0 |a Varma, N.R.S.  |e author 
700 1 0 |a Yusoff, K.  |e author 
773 |t Applied Microbiology and Biotechnology